
Nestlé appoints Paul Navarre as CEO of Nestlé Skin Health
pharmafile | October 12, 2016 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Allergan, Nestle skin health, Paul Navarre, nestle
The announcement of Paul Navarre’s appointed as CEO of Nestlé Skin Health was announced on 11 October. He will take up the new role on the 1 November. His previous role was as president of Allergan’s international business (except the US). He will take over the role from Humberto Antunes.
Paul Navarre is a French national with an MBA from the ISC Paris Business School who started his career with Procter & Gamble where he spent 15 years in different countries and positions involving both consumer goods and healthcare. He then joined Allergan, a global pharmaceutical company, in 2007 where, after various leadership roles over a period of 10 years, he most recently was President of Allergan International.
He brings with him a wealth of experience in skincare, having previously worked with Allergan suite of skin and cosmetic treatments. He also has experience working with Allergan’s blockbuster wrinkle treatment, Botox. This will have been of particular interest to Nestlé in their appointment, as their own portfolio includes Dysport – a Botox alternative.
Related Content

Nestlé to acquire remaining shares in Aimmune for $2.6 billion
Food and drink giant Nestlé has confirmed it is in motion to scoop up the …

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns
The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, …

$63bn Allergan/AbbVie merger review could be delayed by coronavirus
The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles …






